AzTrials
AzTrials

AnesthesiaNCT03539796

Epidural Technique: Does it Really Matter to the Patient?

A study testing Dural puncture epidurals (DPE), Traditional epidurals (EPI) and Combined-spinal epidural technique (CSE) in people with Anesthesia, run by Emory University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The main objective of this study will be to determine if the dural puncture epidural (DPE) provides superior analgesia and better patient satisfaction when compared to traditional epidurals for cesarean sections, and to also determine if patient satisfaction in the DPE group is comparable to that of the CSE technique. Read more about this study

Who is it for?
Ages 18 to 60 years, women only
Conditions the study is for
Anesthesia
What is being tested?
Dural puncture epidurals (DPE), Traditional epidurals (EPI) and Combined-spinal epidural technique (CSE)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
57 participants
Where
1 siteUnited States
Study dates
26 May 2018to 17 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Female parturient at Grady Memorial Hospital must meet one of the following:
  • Parturient having a scheduled or elective cesarean section
  • Parturient not having primary cesarean-section
  • At least 18 years of age
  • Subject has signed the informed consent

Who cannot join

  • Parturient who is unable or unwilling to sign the consent form
  • Parturient having primary cesarean section
  • Parturient with known complex cardiac disease (ex…aortic/mitral stenosis, aortic aneurysms, congenital heart disease with residual defects…etc)
  • Parturient with any contraindication to neuraxial anesthesia such as coagulopathy, infection, or patient refusal
  • Parturient having a fourth or more cesarean section

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Grady Health System (CRN)

    Atlanta, Georgia, 30032

Other trials in United States

About this study

Official title: Dural Puncture Epidural Technique vs. Standard Epidurals vs. Combined-Spinal Epidurals for Cesarean Sections: Does it Really Matter to the Patient?

The main objective of this study will be to determine if the dural puncture epidural (DPE) provides superior analgesia and better patient satisfaction when compared to traditional epidurals for cesarean sections, and to also determine if patient satisfaction in the DPE group is comparable to that of the CSE technique.

Read the detailed description

There are approximately 4 million child birth deliveries in US hospitals per year, and 1.3million of those births are via cesarean section (c-section). With this type of surgery, obstetric anesthesiology plays an important role. The main objective of this study will be to determine if the dural puncture epidural (DPE) provides superior analgesia and better patient satisfaction when compared to traditional epidurals for cesarean sections, and to also determine if patient satisfaction in the DPE group is comparable to that of the CSE technique.

Conditions
Anesthesia
Being tested
Dural puncture epidurals (DPE), Traditional epidurals (EPI), Combined-spinal epidural technique (CSE)
Keywords
dural puncture epidurals, DPE, combined-spinal epidural, CSE, cesarean section, patient satisfaction
Medical subject headings
Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dural puncture epidurals (DPE)Procedure or surgery

    Using the Arrow Epidural Kit (AK-05560) an epidural will be placed using the LOR to saline or air technique. A 26g Gertie Marx needle will be inserted through the Touhy epidural needle and used to puncture the dura; clear, free flowing CSF will return in the needle, but no medications will be injected. The 26g spinal needle will be removed, and the epidural catheter inserted through the epidural needle 3-5cm in the epidural space. A test dose with 3mL 1.5% Lidocaine with 1:200,000 epinephrine will be used to confirm the absence of intrathecal or intravascular catheter placement. The epidural catheter will then be dosed with 0.5% Bupivacaine in 5mL increments until a T4 dermatome level is reached. Epidural fentanyl 100mcg will be administered during initial dosing, and morphine-PF 3mg will be given via epidural after delivery of the fetus.

  • Traditional epidurals (EPI)Procedure or surgery

    Using the Arrow Epidural Kit (AK-05560) an epidural will be placed using the LOR to saline or air technique. The catheter will be inserted 3-5cm in the epidural space. A test dose with 3mL 1.5% Lidocaine with 1:200,000 epinephrine will be used to confirm the absence of intrathecal or intravascular catheter placement. The epidural catheter will then be dosed with 0.5% Bupivacaine in 5mL increments until a T4 dermatome level is reached. Epidural fentanyl 100mcg will be administered during initial dosing, and morphine-preservative free (PF) 3mg will be given via epidural after delivery of the fetus.

  • Combined-spinal epidural technique (CSE)Procedure or surgery

    Using the Arrow Epidural Kit (AK-05560) an epidural will be placed using the LOR to saline or air technique. A 26g Gertie Marx needle will be inserted through the Touhy epidural needle and used to puncture the dura; clear, free flowing CSF will return in the needle and 12mg bupivacaine, 10mcg fentanyl, 200mcg morphine-PF. The 26g spinal needle will be removed, and the epidural catheter inserted through the epidural needle 3-5cm in the epidural space. No epidural test dose will be given immediately compared to the above procedures secondary to intrathecal injection of local anesthetic with this CSE technique. Only after approximately 1 hour after intrathecal injection will a test dose of 3mL 1.5% Lidocaine with 1:200,000 epinephrine will be used to confirm the absence of intrathecal or intravascular catheter placement. The epidural catheter will then be dosed with 0.5% Bupivacaine for the remainder of the procedure if necessary.

Study groups in NCT03539796
Study groupRoleWhat they receive
Dural puncture epidurals (DPE)ExperimentalDural puncture epidurals for cesarean section.
Receives: Procedure: Dural puncture epidurals (DPE)
Traditional epidurals (EPI)Active comparatorTraditional epidurals (EPI) for cesarean section.
Receives: Procedure: Traditional epidurals (EPI)
Combined-spinal epidural technique (CSE)Active comparatorCombined-spinal epidural technique (CSE) for cesarean section.
Receives: Procedure: Combined-spinal epidural technique (CSE)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percent of patients with Numeric Pain Rating Score (NPRS)<1 in the DPE vs. EPI group

    The blinded investigator will visit the patient within 1hour of block placement and ask to select Numeric Pain Rating Score (NPRS) (1-10) during procedure. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable"). Scores range from 0-10 points, with higher scores indicating greater pain intensity.

    Measured: 1 hour after procedure

  2. Percent of patients with Numeric Pain Rating Score (NPRS) <3 in the DPE vs. EPI group.

    The blinded investigator will visit the patient 3 hours within 1hour of block placement and ask to select Numeric Pain Rating Score (NPRS) (1-10) during procedure.The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable"). Scores range from 0-10 points, with higher scores indicating greater pain intensity.

    Measured: 1 hour after procedure

  3. Percent of patients with Numeric Pain Rating Score (NPRS)<1 in the DPE vs. CSE group

    The blinded investigator will visit the patient within 1hour of block placement and ask to select Numeric Pain Rating Score (NPRS) (1-10) during procedure.The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable"). Scores range from 0-10 points, with higher scores indicating greater pain intensity.

    Measured: 1 hour after procedure

Secondary outcomes (2)
  1. Percent of patients required rescue analgesia in the DPE vs. EPI group

    Additional sedation administered during procedure will be documented.

    Measured: During labor/delivery (up to 24 hours)

  2. Percent of patients required rescue analgesia in the DPE vs. CSE group

    Additional sedation administered during procedure will be documented. .

    Measured: During labor/delivery (up to 24 hours)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2018
  2. Study start26 May 2018
  3. Primary completion17 Jul 2022
  4. Study completion17 Jul 2022

Why it stopped: This study was terminated early because of shortage of supplies with no foreseeable future of when they will be back in stock.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
57 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03539796
Sponsor's protocol ID
IRB00098730
Status last verified
Jan 2023
First submitted
16 May 2018
Last updated
12 Jan 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Dural puncture epidurals (DPE), Traditional epidurals (EPI) and Combined-spinal epidural technique (CSE) in people with Anesthesia, run by Emory University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 12 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: This study was terminated early because of shortage of supplies with no foreseeable future of when they will be back in stock.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percent of patients with Numeric Pain Rating Score (NPRS)<1 in the DPE vs. EPI group (time frame: 1 hour after procedure). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2023; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in